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Athletic injuries of the locomotor apparatus were, are and always will be the widespread type of traumatic injuries, which not only influence on sportsmen achievements, but also worsen the quality of their life in whole [4, 8, 11, 13, 14, 19] . Especially it concerns the athletes of high qualification -athletic injuries, particularly, injuries of joints, exclude them from the training process and sporting contests for a long period or completely [10, 12, [15] [16] [17] .
Currently, soft dosage forms in the form of liniments, ointments, creams, gels have been widely used in rehabilitation of injured joints [9, 18] . They are the complex heterogeneous disperse systems, which quality, efficiency and safety depend on the type and composition of a base-carrier, disperse state of medicinal substances, expedience of application and correct choice of excipients, preservatives, conditions of production, storage, etc. Soft dosage forms are simple for application, can combine several active substances of different activity direction in the same dosage form, and also provide duration of the presence of active substances directly in the site of drug application, etc. [2, 3] .
The aim of this work is to carry out the marketing analysis of the assortment of medicines used topically for diseases of the locomotor apparatus presented at the pharmaceutical market of Ukraine for the subsequent substantiation of the composition and the type of a soft dosage form for a complex medicine, which is planned to application in sports medicine.
Materials and Methods
The object of our research was the information about the structure of the market of medicines used topically for diseases of the locomotor apparatus registered in Ukraine, as well as about their price (marketing) descriptions for 2005-2012. Graphic and logical methods are used.
Results and Discussion
The segment of medicines used topically for diseases of the locomotor apparatus consists of the products re-gistered both as medicines and as dietary supplements [5] [6] [7] . The medicines were presented according to the ATC-classification in the group "M -musculo-skeletal system", its capacity was ~6% from the capacity of the pharmaceutical market of Ukraine in natural terms and ~8% in money terms as of 2012 [1, [5] [6] [7] . The dietary supplements were presented in the group "Y09 -supplements for treatment of diseases of the locomotor apparatus", as of 2012 its capacity was ~3.5% and ~4% in natural and money terms from the sales volume of dietary supplements in Ukraine, respectively. In turn, the segment is provided by medicines in ~96% and only in ~4% by dietary supplements [1, [5] [6] [7] .
As for the current state of the pharmaceutical branch of Ukraine in the segment of products used topically for treating diseases of the locomotor apparatus, the medicines are registered directly in the group "M02A -topical products for joint and muscular pain"; its capacity was ~1.6% from the capacity of the pharmaceutical market of Ukraine in natural terms and ~1.7% in money terms as of 2012 [1, [5] [6] [7] . The weighted average increase rate of the group for the period investigated has the tendency to decrease.
Dietary supplements are presented in several groups -"Y09A2 -topical anti-inflammatory products", "Y09B1 -products for treatment of contusions and injuries" and "Y09B2 -massage products". The capacity of the virtual group of dietary supplements consisting of products of three groups mentioned above and used topically for treatment of diseases of the locomotor apparatus was ~2.8% and ~2.6% in natural and money terms from the capacity of the pharmaceutical market of Ukraine as of 2012 [1, [5] [6] [7] . The weighted average increase rate of the virtual group of dietary supplements for the period investigated has also the tendency to decrease.
In general, the segment of the products investigated is provided by medicines in ~89% and only in ~11% by dietary supplements by the sales volume [1, [5] [6] [7] . It should be noted that over the last 7 years significant changes in sale distribution between the medicines for topical application in treating the locomotor apparatus and the dietary supplements used for the same purpose have not occurred. The insignificant increase of the share of the dietary supplements segment was observed in 2012 as compared to the beginning of the period under research in 2005.
In 2012 the group of the dietary supplements selected consisted of 313 trade names, at the same time the medicines are presented by 101 trade names [5] [6] [7] .
The virtual group selected for analysis consists of such dosage forms as gels, ointments, creams, balsams, liniments and emulsions, solutions (alcoholic, oil, aqueous), applications and plasters, oils, sprays and extracts. The medicines produced in the form of gel were the leaders of sales acoording to the results of 2012, solutions and ointments occupied the second and third place, respectively. The negative dynamics was observed for such forms as ointments, balsams and liniments/emulsions; the situation was succeeded in improving for creams, applications/plasters and spray forms as compared with 2011. In the structure of the segment under research the soft dosage forms (except applications and plasters) occupy 68.28% in packs and 84.42% in money terms according to the results of 2012 (Fig. 1, 2) ; it indicates that they are the main forms used for topical treatment of diseases of the locomotor apparatus. In general, stagnation is observed in the share of the soft dosage forms segment among the products used topically for diseases of the locomotor apparatus.
Both domestic and foreign producers are presented widely enough in the segment. The results presented in Fig. 3 indicate that the ratio between the volumes of supply is approximately permanent over all period of observations, although the participation of domestic producers, however, has the tendency to decrease in natural terms.
In 2012 the segment of soft dosage forms (except applications and plasters) was provided by 85 international nonproprietary names (INN) presented both in the group of medicines and in the group of dietary supplements. Such substances as diclofenac -22.79%, ibuprofen -8.67%, ketoprofen -7.67%, comfrey -7.37%, Fig. 3 . Dynamics of the ratio of supply of domestic and foreign producers in the segment of soft dosage forms (except applications and plasters). dimethyl sulfoxide in combination with heparin -6.32%, nimesulide -4.93%, chondroitin sulphate -3.60%, combination of apitoxin with methyl salicylate and allyl isothiocyanate -3.53%, different combinations -3.21%, combination of diclofenac with methyl salicylate and menthol -2.93%, nonivamide with nicoboxil -2.91%, homoeopathic products -2.74%, combination of viper poison with salicylic acid and turpentine -1.86% and the extract of hot pepper in combination with dimethyl sulfoxide -1.67% (14 substances in all) provide 80% of sales in packs (Fig. 4) . Only 11 substances provide 80% of sales in money terms (Fig. 5) : diclofenac -17.84%, ibuprofen -11.22%, combination of dimethyl sulfoxide with heparin and dexpanthenol -9.26%, comfrey -8.74%, ketoprofen -8.26%, homoeopathic products -8.00%, chondroitin sulphate -6.44%, nimesulide -3.88%, nonivamide in combination with nicoboxil -3.45%, combination of apitoxin with methyl salicylate and allyl isothiocyanate -2.78%, as well as combination of diclofenac with methyl salicylate and menthol -2.23%.
The leadership of diclofenac and ibuprofen -both in money equivalent and in packs -attracts the attention; the first substance is presented by 17 international nonproprietary names, the second -by 4 ones [5] [6] [7] .
Thus, it is expedient to work in direction of creating soft dosage form, namely gels, for creation of a new complex medicine for application in sport medicine. CONCLUSIONS 1. The marketing research of the market of medicines used topically for diseases of the locomotor apparatus has been carried out.
2. It has been found that the quantitative and qualitative variety of medicines used topically for diseases of the locomotor apparatus is presented both by products of foreign firms and domestic producers.
3. It has been determined that the medicines produced in the form of gel are the leaders of sales -both in natural terms and in money equivalent. 4 . It has been shown that in the structure of the segment under research the soft dosage forms (except applications and plasters) occupy 68.28% in packs and 84.42% in money terms; they are presented by 85 international nonproprietary names registered both as medicines and as dietary supplements. The undisputed leaders in the segment are diclofenac and ibuprofen. 
